Trial intelligence / Profile preview

Comparison of labetalol and dexmedetomidine on bleeding during endoscopic sinus surgery

IRCT2016080914056N8Phase 2Completed

Sponsor
Arak University of Medical Sciences
Start
Jan 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised trial in rhinosinusitis comparing labetalol arm with dexmedetomidine arm (2 arms). Primary endpoint: intraoperative bleeding during endoscopic sinus surgery. Started Jan 2016; status: completed.

02

Drugs

labetaloldexmedetomidine
03

Conditions

rhinosinusitis

Beyond the preview

Go deeper on IRCT2016080914056N8.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2016080914056N8.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call